While these studies revealed candidate transcripts whose dysregulation might contribute to motoneuron dysfunction in ALS, it needs to be considered that overexpression of SOD1 or TDP-43 might induce deleterious side effects in a dose-dependent manner [45]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.